CP is an oxazaphosphorine alkylating agent used as a broad-spectrum antineoplastic agent and as immunosuppressant in non-neoplastic conditions like systemic lupus erythematosus and rheumatoid arthritis. This evidence concerns the gene CP and systemic lupus erythematosus.